Neurophet

Neurophet Intangible Assets

The Intangible Assets of Neurophet (380550.KQ) as of Oct 19, 2026 is 470.29 M KRW. In the previous year, Intangible Assets was 468.45 M KRW — a change of 0.39% (higher).

Intangible Assets

470.29 MKRW

YoY

0.39%

Last updated:

Intangible Assets of Neurophet is 2024 470.29 M KRW. Intangible Assets of Neurophet was 2023 468.45 M KRW. It decreases by 0.39% higher compared to the previous year.

The Neurophet Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2022
415.73 M KRW
Jan 1, 2023
468.45 M KRW
Jan 1, 2024
470.29 M KRW
The Neurophet Intangible Assets history
YEARIntangible AssetsYoY
470.29 MKRW+0.39%
468.45 MKRW+12.68%
415.73 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neurophet Stock analysis

What does Neurophet do? Neurophet Inc is a South Korean company operating in the Health Care sector, headquartered in Seoul. The company has 135 employees and is listed on the Korean stock exchange with the ticker 380550.KQ and ISIN KR7380550004. Neurophet Inc went public on July 25, 2025, marking its initial public offering. The company focuses on the research, development, and sales of brain imaging analysis software, including PET image quantitative analysis software called 'Neurophet SCALE PET' and neurodegenerative brain disease diagnosis support software named 'Neurophet AQUA'. Additionally, Neurophet Inc develops and sells therapeutic medical devices and provides medical artificial intelligence solutions. The company's website is https://www.neurophet.com/. Neurophet Inc operates within the Health Care Technology industry, specializing in software and AI-driven tools for medical imaging and diagnostics. The company's products are designed to support healthcare professionals in analyzing brain imaging data and diagnosing neurological conditions. As a technology-focused health care provider, Neurophet Inc aims to enhance diagnostic accuracy and efficiency through its software solutions. The company's operations are based in Seoul, South Korea, and it is engaged in both the development and commercialization of its medical technology products. Neurophet Inc's business model centers on creating innovative software tools that address specific challenges in neurology and brain imaging analysis. Neurophet is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neurophet stock

Intangible Assets of Neurophet is 470.29 M KRW in 2024.

Intangible Assets of Neurophet changed from 468.45 M KRW to 470.29 M KRW, representing a 0.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Neurophet since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Neurophet historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Neurophet

All Key Metrics — Neurophet